HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Estrogen receptor binding radiopharmaceuticals: II. Tissue distribution of 17 alpha-methylestradiol in normal and tumor-bearing rats.

Abstract
Tritiated 17 alpha-methylestradiol was synthesized to investigate the potential of the carbon-11-labeled analog as an estrogen-receptor-binding radiopharmaceutical. In vitro, 17 alpha-methylestradiol is bound with high affinity to the cytoplasmic estrogen receptor from rabbit uterus (Kd = 1.96 x 10(-10)M), and it sediments as an 8S hormone-receptor complex in sucrose gradients. The compound shows specific uptake in the uterus of the adult rat, within 1 hr after injection. After 30 min the uterine uptake was 1.73% dose/g. In female rats bearing DMBA-induced tumors, specific uterine and tumor uptakes were observed, although at 30 min the tumor uptake was only 23-30% of the uptake in the uterus. Tritiated 17 alpha-methylestradiol with a specific activity of 6 Ci/mmole showed a similar tissue distribution. Our results indicate that 17 alpha-methylestradiol is promising as an estrogen-receptor-binding radiopharmaceutical.
AuthorsA Feenstra, W Vaalburg, G M Nolten, S Reiffers, A G Talma, T Wiegman, H D van der Molen, M G Woldring
JournalJournal of nuclear medicine : official publication, Society of Nuclear Medicine (J Nucl Med) Vol. 24 Issue 6 Pg. 522-8 (Jun 1983) ISSN: 0161-5505 [Print] United States
PMID6406650 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Receptors, Estrogen
  • 17-methylestradiol
  • Estradiol
  • 9,10-Dimethyl-1,2-benzanthracene
Topics
  • 9,10-Dimethyl-1,2-benzanthracene
  • Animals
  • Estradiol (analogs & derivatives, metabolism)
  • Female
  • Mammary Neoplasms, Experimental (chemically induced, metabolism)
  • Rats
  • Rats, Inbred Strains
  • Receptors, Estrogen (metabolism)
  • Tissue Distribution
  • Uterus (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: